Furmanski
Anna L. Furmanski, London GB
Patent application number | Description | Published |
---|---|---|
20150037350 | NEGATIVE MODULATOR OF HEDGEHOG SIGNALLING FOR USE IN TREATING TH2-MEDIATED DISEASES - The invention provides means for treating Th1- and Th2-mediated diseases, such as asthma, allergic dermatitis and Th2-driven cancer. The invention extends to pharmaceutical compositions for use in treating such conditions, and to methods of treatment. The invention also extends to adjuvants and vaccines per se, and to their use in enhancing the immunomodulatory activity of immunogens. | 02-05-2015 |
Brian Furmanski, Columbia, SC US
Patent application number | Description | Published |
---|---|---|
20110100821 | MINERAL OIL FREE ISOELECTRIC FOCUSING APPARATUS FOR IMMOBILIZED PH GRADIENT STRIPS - A protective sheath for use with an immobilized pH gradient (IPG) strip in an isoelectric focusing (IEF) process is generally disclosed. The protective sheath can inhibit dehydration of the IPG strip during use through loss of water to the atmosphere and/or migration of water due to electroosmotic flow without the use of mineral oil or another water-immiscible liquid. The protective sheath can generally be configured in a tube-like shape having an inner cavity. The protective sheath can define a top surface, a bottom surface, two side surfaces, a sealed end, and an open end. The top surface can have at least 2 openings, which can be covered by pull-tabs. | 05-05-2011 |
Brian Furmanski, Memphis, TN US
Patent application number | Description | Published |
---|---|---|
20090258941 | USE OF FUSAROCHROMANONE AND ITS DERIVATIVES IN THE DIAGNOSIS AND TREATMENT OF CANCER AND OTHER DISEASES - A method of photodynamic therapy to treat diseased cells in an animal is generally provided. According to the method, 5-amino-2,2-dimethyl-6-[3′-(R,S)amino-4′-hydroxy-butan-1-one]-2,3-dihydro-4H-1-benzopyran-4-one or an analog thereof is administered to the animal such that the 5-amino-2,2-dimethyl-6-[3′-(R,S)amino-4′-hydroxy-butan-1-one]-2,3-dihydro-4H-1-benzopyran-4-one or an analog thereof accumulates in the diseased cells. Then, the diseased cells containing 5-amino-2,2-dimethyl-6-[3′-(R,S)amino-4′-hydroxy-butan-1-one]-2,3-dihydro-4H-1-benzopyran-4-one or an analog thereof is exposed to light energy (e.g., ultraviolet light). | 10-15-2009 |
20140031739 | Use of Fusarochromanone and Its Derivatives in the Diagnosis and Treatment of Cancer and Other Diseases - A method of photodynamic therapy to treat diseased cells in an animal is generally provided. According to the method, 5-amino-2,2-dimethyl-6-[3′-(R,S)amino-4′-hydroxy-butan-1-one]-2,3-dihydro-4H-1-benzopyran-4-one or an analog thereof is administered to the animal such that the 5-amino-2,2-dimethyl-6-[3′-(R,S)amino-4′-hydroxy-butan-1-one]-2,3-dihydro-4H-1-benzopyran-4-one or an analog thereof accumulates in the diseased cells. Then, the diseased cells containing 5-amino-2,2-dimethyl-6-[3′-(R,S)amino-4′-hydroxy-butan-1-one]-2,3-dihydro-4H-1-benzopyran-4-one or an analog thereof is exposed to light energy (e.g., ultraviolet light). | 01-30-2014 |
Christopher Furmanski, Tarzana, CA US
Patent application number | Description | Published |
---|---|---|
20100061695 | METHOD AND APPARATUS FOR PRODUCING RE-CUSTOMIZABLE MULTI-MEDIA - The present invention is a method and system that facilitates the production of personalized movies. The invention enables the repeated and high-volume generation of unique, customized multi-media (e.g., movies) from a collection of stock media. A production method for creating personalized movies comprises the steps of receiving user-provided media, receiving parameters which define how the user wants the movies to be personalized, and integrating the user-provided media into predefined spatial and temporal portions of stock media utilizing a compositing algorithm to form a composited movie. In addition, the method may also include the step of comparing and rescheduling production tasks along relevant dimensions utilizing an optimization algorithm in accordance with received parameters. | 03-11-2010 |
George Furmanski, La Quinta, CA US
Patent application number | Description | Published |
---|---|---|
20110049062 | PROCESS FOR PRODUCING ELECTROLYTIC MANGANESE DIOXIDE - This invention relates generally to processes for extracting iron and/or calcium from geothermal brines. | 03-03-2011 |
20130068697 | PROCESS FOR DEPLETING CALCIUM AND/OR IRON FROM GEOTHERMAL BRINES - This invention relates generally to processes for extracting iron and/or calcium from geothermal brines. | 03-21-2013 |
20150076064 | PROCESS FOR DEPLETING CALCIUM AND/OR IRON FROM GEOTHERMAL BRINES - This invention relates generally to processes for extracting iron and/or calcium from geothermal brines. | 03-19-2015 |
Martin Furmanski, Malmo SE
Patent application number | Description | Published |
---|---|---|
20110040502 | METHOD AND DEVICES FOR MONITORING FLOW CIRCUITS - A device is provided for monitoring the integrity of a flow circuit in fluid communication with a receptacle. The flow circuit comprises a pumping device for transferring fluid through the flow circuit. The device operates according to a monitoring method in which a pressure signal is received from a pressure sensor, the pressure signal being indicative of fluid pressure in the receptacle or the flow circuit. The pressure signal is then processed for detection of a beating signal. The beating signal manifests itself as an amplitude modulation of the pressure signal and is formed by interference between pressure waves generated by a pulse generator associated with the receptacle and pressure waves generated by the pumping device. The integrity of the flow circuit is determined based at least partly on the presence or absence of the beating signal. The device and the flow circuit may be part of an apparatus for extracorporeal blood treatment, and the method may be implemented as a computer program product. | 02-17-2011 |
20110106466 | METHODS AND DEVICES FOR MONITORING THE INTEGRITY OF A FLUID CONNECTION - A surveillance device monitors the integrity of a fluid connection between first and second fluid containing systems based on at least one time-dependent measurement signal from a pressure sensor in the first fluid containing system. The first fluid containing system comprises a first pulse generator, and the second fluid containing system comprises a second pulse generator. The pressure sensor is arranged to detect first pulses originating from the first pulse generator and second pulses originating from the second pulse generator. The integrity of the fluid connection is determined based on the presence of second pulses in the measurement signal. The second pulses may be detected by analysing the measurement signal in the time domain and/or by using timing information indicative of the timing of the second pulses in said at least one measurement signal. The analysis may be based on a parameter value that represents a distribution of signal values within a time window of the measurement signal. The parameter value may be calculated as a statistical dispersion measure of the signal values, or may result from a matching of the signal values within the time window to a predicted temporal signal profile of a second pulse. The fluid connection may be established between a human blood system and an extracorporeal blood flow circuit. | 05-05-2011 |